| Literature DB >> 33105571 |
Dayakar Thatikayala1, Deepalekshmi Ponnamma2, Kishor Kumar Sadasivuni2, John-John Cabibihan3, Abdulaziz Khalid Al-Ali4, Rayaz A Malik5, Booki Min1.
Abstract
Non-enzymatic sensing has been in the research limelight, and most sensors based on nanomaterials are designed to detect single analytes. The simultaneous detection of analytes that together exist in biological organisms necessitates the development of effective and efficient non-enzymatic electrodes in sensing. In this regard, the development of sensing elements for detecting glucose and hydrogen peroxide (H2O2) is significant. Non-enzymatic sensing is more economical and has a longer lifetime than enzymatic electrochemical sensing, but it has several drawbacks, such as high working potential, slow electrode kinetics, poisoning from intermediate species and weak sensing parameters. We comprehensively review the recent developments in non-enzymatic glucose and H2O2 (NEGH) sensing by focusing mainly on the sensing performance, electro catalytic mechanism, morphology and design of electrode materials. Various types of nanomaterials with metal/metal oxides and hybrid metallic nanocomposites are discussed. A comparison of glucose and H2O2 sensing parameters using the same electrode materials is outlined to predict the efficient sensing performance of advanced nanomaterials. Recent innovative approaches to improve the NEGH sensitivity, selectivity and stability in real-time applications are critically discussed, which have not been sufficiently addressed in the previous reviews. Finally, the challenges, future trends, and prospects associated with advanced nanomaterials for NEGH sensing are considered. We believe this article will help to understand the selection of advanced materials for dual/multi non-enzymatic sensing issues and will also be beneficial for researchers to make breakthrough progress in the area of non-enzymatic sensing of dual/multi biomolecules.Entities:
Keywords: advanced nanomaterials; bi-functional properties; dual in-line sensing; electrochemical sensing; glucose and H2O2; non-enzymatic
Mesh:
Substances:
Year: 2020 PMID: 33105571 PMCID: PMC7690282 DOI: 10.3390/bios10110151
Source DB: PubMed Journal: Biosensors (Basel) ISSN: 2079-6374
Figure 1Schematic illustration of advanced nanomaterials for non-enzymatic electrochemical glucose and H2O2 sensing: (a) AuNBP/MWCNT/GCE nanocomposites [35]; (b) Ni3N/GA samples [36]; (c) 3D N-Co-CNT@NG [37]; (d) Cu2O PLNWs/Cu foam [38]; (e) core shell NixCo3-xN/NG [39]; (f) Ni (OH)2/RGO/Cu2O@Cu electrode [40].
Figure 2Co3N NW/TM: (a) XRD pattern; (b and c) SEM images of Co (Co(OH)2/TM; (d) ampherometric i-t response of Co3N NW/TM at 0.55 V (vs Hg/HgO with successive addition of glucose with varying concentration from 20 μM to 5.5 mM); (e) corresponding calibration curve of Co3N NW/TM for the detection of glucose; (f) interference studies in the presence of glucose; (g) ampherometric i-t response of Co3N NW/TM at 0.55 V (vs Hg/HgO with successive addition of H2O2 with varying concentration from 20 μM to 5.5 mM); (h) corresponding calibration curve of Co3N NW/TM for detection H2O2; (i) interference studies in the presence of H2O2 [56].
Performances of non-enzymatic glucose and H2O2 electrochemical sensors based on metal nanocomposites.
| Electrode Material | Analyte | Sensitivity | Linear Range | Detection Limit | Working Potential | Stability | Repeatability | Reproducibility | Real-Time Application | Ref |
|---|---|---|---|---|---|---|---|---|---|---|
| AuNBP/MWCNTs | Glucose | 101.2 | 10 to 36.7 | 3.0 | 0.15 | 98.0% | - | 2.3 | Human serum | [ |
| H2O2 | 170.6 | 5.0 to 47.3 | 1.5 | −0.50 | 94.7% | - | 3.5 | Antibacterial lotion | ||
| Ag–CNx/GCE | Glucose | 97 | 0.001 to 0.1 | 0.6 | 0.7 | - | - | - | [ | |
| H2O2 | 1.7 × 104 | 0.005 to 0.35 | 0.0045 | −0.7 | - | - | - | |||
| PCF Cu NP/GCE | Glucose | - | 6.6 to 1.3 | 2.2 | 0.35 | 96% (60 days) | 3.5 | human urine | [ | |
| H2O2 | - | 8.3 to 1.5 | 2.7 | 0 | - | 3.8 | antiseptic solution | |||
| Graphene/pectin-Cu NPs/GCE | Glucose | 0.0457 | 10 to 0.0055 | 2.1 | 0.40 | 6.83% | 2.35 | 2.82 | Human serum | [ |
| H2O2 | 0.391 | 1 to 1 | 0.35 | −0.20 | 5.3% | 2.52 | 2.92 | Contact lens solution | ||
| Cu2S NRs@Cu foam | Glucose | 11 750.8 | 0.2 to 0.63 | 0.07 | 0.45 | 94.8 (14 days) | 3.26 | 2.12 | Human serum | [ |
| H2O2 | 745 | 0.25 to 5 | 0.12 | −0.2 | 95.6 (14 days) | 0.49 | 2.03 | - | ||
| PCF Ni NP/GCE | Glucose | 42.3 | 1.6 to 1.4 | 0.53 | 0.50 | - | 1.7 | - | - | [ |
| H2O2 | 43 | 3.3 to 1.7 | 1.10 | 0.50 | - | 1.8 | - | - | ||
| 3D flower-like Ni7S6/GCE | Glucose | 271.80 | 5 to 3.70 | 0.15 | 0.45 | 97.1 | - | 1.33 | Human serum | [ |
| H2O2 | 37.77 | 5 to 20.50 | 0.15 | −0.35 | 95.8 | - | 0.92 | Antibacterial lotion | ||
| Ni5.5Co1.5S6/GCE | Glucose | 494.58 | 5 to 0.50 | 0.15 | 0.425 | 89.9 | - | 1.2 | Human serum | [ |
| H2O2 | 94.79 | 5 to 15.09 | 0.15 | −0.35 | 95.2 | - | 2.1 | Antibacterial lotion | ||
| Ni3N/GA/GCE | Glucose | 905.6 | 0.1 to 7.64 | 0.04 | 0.55 | 93 | - | 4.6 | Human serum | [ |
| H2O2 | 101.9 | 5 to 75.13 | 1.80 | −0.4 | 95.2 (15 days) | - | 3.3 | Human serum | ||
| CoS/GCE | Glucose | 28.44 | 1200 to 10.20 | 1.5 | 0.20 | - | - | - | Antibacterial lotion | [ |
| H2O2 | 17.4 | 5 to 14.82 | 1.5 | −0.40 | - | - | - | Human serum | ||
| 3D N-Co-CNT@NG/GCE | Glucose | 9.05 | 2.5 to 10.83 | 0.1 | 0.32 | 94.68 | 3.3 | 3.8 | Human serum | [ |
| H2O2 | 28.66 | 2.0 to 7.449 | 2.0 | −0.04 | 96.49 | - | 4.2 | Human serum | ||
| Co3N NW/titanium mess | Glucose | 3325.6 | 0.1 to 2.5 | 0.05 | 0.60 | 91.5 | - | 4.3 | Human serum | [ |
| H2O2 | 139.9 | 1 to 12 | 0.48 | −0.20 | 92.1 | - | 5.2 | - | ||
| Co/TPEG2/BAPc/MWCNTs/GCE | Glucose | 1.970 | 5 to 0.05 (M/L) | 12.5 (M/L) | 0.50 | - | 1.9 | 2.1 | Human serum | [ |
| H2O2 | 0.162 | 5 to 0.05 | 10 (M/L) | −0.50 | - | - | - | Contact lens solutions | ||
| Cu@N-Chit–CNTs | Glucose | - | 0.5 to 1 | 0.05 | 0.50 | 93 | - | - | Human serum | [ |
| H2O2 | - | 0.1 to 1 | 0.025 | −0.25 | 92 | - | - | Processed milk | ||
| Pt/OMCs/Nafion/GC | Glucose | 16.69 | 500 to 4.5 | 130 | −0.08 | 93.2 (14 days) | - | 7.4 | - | [ |
| H2O2 | 173.4 | 2 to 4.212 | 1.2 | −0.10 | 94.6 (14 days) | - | 5.2 | - | ||
| VO(acac)2–PATP–Au/GCE | Glucose | 120.24 | 1 to 0.5 | 0.1 | 0.65 | 100 (20 days) | - | 0.2 | Human blood | [ |
| H2O2 | 326.66 | 0.02 to 0.9 | 0.03 | −0.11 | 100 (20 days) | - | 0.3 | Milk | ||
| VS2/GCE | Glucose | 41.96 | 0.5 to 3.0 | 0.211 | - | 92% (20 days) | - | 2.7 | human serum | [ |
| H2O2 | 37.96 | 0.5 to 2.5 | 0.224 | −0.75 | - | - | - | Hair dye and Human urine | ||
| g-C3N4/GCE | Glucose | - | 1000 to 12 | 11 | −0.81 | 81% (40 days) | - | - | - | [ |
| H2O2 | - | 100 to 90 | 2.0 | −0.30 | - | - | - | - |
Performance of non-enzymatic glucose and H2O2 electrochemical sensors based on metal oxide nanocomposites.
| Electrode Material | Analytes | Sensitivity | Linear Range | Detection Limit | Working Potential | Stability | Repeatability | Reproducibility | Real-Time Application | Ref |
|---|---|---|---|---|---|---|---|---|---|---|
| CuO nanoflowers/GCE | Glucose | 1086.34 | 1 to 2.79 | 0.12 | 0.5 | 85.40 | 1.37 | 4.28 | Urine | [ |
| H2O2 | 956.69 | 5 to 14.07 | 0.85 | −0.4 | 89.77 | 2.69 | 5.38 | Milk | ||
| CuO-Tyr Modified electrode | Glucose | 9.02 | 900 to 16 | 20 | 0.60 | 97 | - | 2.5 | - | [ |
| H2O2 | 2.72 | 100 to 36 | 2 | −0.25 | - | - | - | - | ||
| CuO/PANI/GCE | Glucose | - | 1 to 9.899 | 0.45 | 0.3 | - | - | - | - | [ |
| H2O2 | - | 5 to 9.255 | 0.11 | −0.2 | - | - | - | - | ||
| CuO nanorods/FTO | Glucose | 1319 | 5 to 0.825 | - | 0.55 | 80 | - | - | - | [ |
| H2O2 | 84.89 | 250 to 18.75 | - | −0.5 | 70 | - | - | - | ||
| Porous CuO/GCE | Glucose | −70.8 | 1.5 to 0.5 | 0.8 | 0.60 | 88.6 (21 days) | - | - | - | [ |
| H2O2 | 50.6 | 5 to 1.5 | 1.5 | −0.20 | 87 (21 days) | - | - | - | ||
| Cu2O/GCE | Glucose | - | 50 to 1.1 | 47.2 | 0.50 | - | - | - | - | [ |
| H2O2 | 3.693 | - | 0.039 | −0.20 | - | - | - | - | ||
| MCHNs/GCE | Glucose | 52.5 | 1 to 1.7 | 0.87 | 0.6 | - | - | - | - | [ |
| H2O2 | 156.6 | 2 to 0.15 | 1.03 | −0.3 | - | - | - | - | ||
| Cu2O/GNs | Glucose | 0.285 | 300 to 3.3 | 3.3 | 0.60 | - | - | - | - | [ |
| H2O2 | - | 300 to 7.8 | 20.8 | −0.40 | - | - | - | - | ||
| CQDs/octahedral Cu2O/GCE | Glucose | 0.298 | 20 to 4.3 | 8.4 | 0.60 | High stability | - | - | Human serum | [ |
| H2O2 | 0.13 | 5 to 5.3 | 2.8 | −0.2 | High stability | - | - | - | ||
| Cu2OMS–RGO/GCE | Glucose | - | 1 to 0.419 | 0.73 | 0.6 | 87.6 | - | - | - | [ |
| H2O2 | - | 50 to 2.775 | 10.8 | −0.24 | 89 | - | - | - | ||
| Cu2O PLNWs/Cu foam | Glucose | 6680.7 | 1 to 1.8 | 0.67 | 0.5 | 98.9 (7 days) | 4.61 | 2.57 | - | [ |
| H2O2 | 1477.3 | 5 to 1.77 | 0.13 | −0.3 | 98.4 (7 days) | 0.59 | 1.28 | - | ||
| Co3O4 NPs/GCE | Glucose | 520.7 | 5 to 0.8 | 0.13 | 0.59 | - | - | - | Human serum | [ |
| H2O2 | 107.4 | - | 0.81 | +0.42 | - | - | - | Disinfectant | ||
| GF/Co3O4-NPs | Glucose | 13.52 | 500 to 16.5 | 50.0 | −0.55 | 89 (9 days) | 3.9 | 3.7 | - | [ |
| H2O2 | 1.14 | 0.2 to 0.211 | 0.06 | −0.48 | 97.3 (9 h) | 3.2 | 2.2 | - | ||
| ITO/NiO | Glucose | 1013.76 | 2 to 0.29 | 4.6 | 0.5 | 80 (15 days) | - | 3 | Human serum | [ |
| H2O2 | 82.73 | 10 to 0.87 | 5.2 | −0.46 | 90 (15 days) | - | 3.5 | - | ||
| Ni(OH)2/ERGO-MWCNTs/GCE | Glucose | 2042 | 1 to 1.5 | 2.7 | 0.54 | 5.9 | 2.8 | Urine | [ | |
| H2O2 | 711 | 20 to 9.05 | 4.0 | 0.2 | 6.1 | 2.8 | Milk |
Figure 3Schematic representation of CuO NRs: (a) glucose oxidation; (b) H2O2 reduction; (c) interference study during glucose sensing after the addition of 0.1 mM of DA, UA, AA, UR and SU and 0.5 mM of H2O2 along with 0.5 mM glucose; (d) interference during H2O2 sensing during the addition of 0.1 mM DA, UA, AA, UR, SU and 0.5 mM of glucose along with 0.5 mM H2O2 [66].
Figure 4(a) Schematic diagram for preparation of Pd-CoCNT; (b) HRTEM images of Pd-CoCNT [85].
Performance of non-enzymatic glucose and H2O2 electrochemical sensors based on metal/metal nanocomposites.
| Electrode Material | Analyte | Sensitivity | Linear Range | Detection Limit | Working Potential | Stability | Repeatability | Reproducibility | Real-Time Application | Ref |
|---|---|---|---|---|---|---|---|---|---|---|
|
| Glucose | - | 200 to 5.4 | 0.5 | 0.6 | High (14 days) | 2.43 | 2.97 | - | [ |
| H2O2 | - | 50 to 2.75 | 0.1 | +0.7 | 95.9 (13 days) | 2.61 | 3.02 | - | ||
|
| Glucose | 0.499 | 50 to 3 | 0.1 | 0.6 | - | - | - | - | [ |
| H2O2 | - | 50 to 0.8 | 1.0 | +0.70 | 93 (14 days) | 2.1 | 3.4 | - | ||
|
| Glucose | 11.75 | 1000 to 16 | 300 | −0.15 | Human serum | [ | |||
| H2O2 | 218.97 | 2.5 to 41.605 | 0.75 | −0.40 | 92 | 1.2 | Antibacterial lotion and lake water | |||
|
| Glucose | 85,910.0 | 0.1 to 9.0 | 0.03 | 0.1 | 96.9 | - | 0.88 | Human serum | [ |
| H2O2 | 2123.10 | 0.2 to 24.6 | 0.06 | −0.45 | 97.9 | - | 2.2 | Lake water | ||
|
| Glucose | 0.75 | 1000 to 38 | 1.8 | 0.35 | High stability | - | - | - | [ |
| H2O2 | 72 | 100 to 1.9 | 3.1 | 1.2 | 93.1 (14 days) | 1.7 | 3.2 | - | ||
|
| Glucose | 2.7 | 1000 to 32 | 1.6 | 0.35 | High stability | - | - | - | [ |
| H2O2 | 38.72 | 500 to 6.0 | 2.1 | +0.9 | 95.9 (13 days) | 2.3 | 3.1 | - | ||
|
| Glucose | 0.75 | 1000 to 25.00 | 1.90 | 0.35 | High stability | - | - | - | [ |
| H2O2 | 208.60 | 50 to 1.00 | 2.10 | +1.0 | 91.5 (operational stability 2000 s | - | 3.2 | - | ||
|
| Glucose | - | 500 to 20 | 400 | −0.1 | High (15 days) | 4.4 | 8.2 | - | [ |
| H2O2 | 184.9 | 0.8 to 10 | 0.16 | −0.1 | 98 (15 days) | 9.0 | 7.5 | - | ||
|
| Glucose | 3.77 | 10 to 2.4 | 1 | 0.5 | 88.8 (4 days) | - | 7.3 | Human serum | [ |
| H2O2 | - | 2100 to 10.1 | 0.3 | −0.15 | - | - | - | - | ||
|
| Glucose | - | 0.5 to 14 | 0.1 | 0.65 | 95 (3 Months) | - | - | Human serum | [ |
| H2O2 | - | 1.0 to 11 | 0.75 | −0.40 | 95 (3 Months) | - | - | - | ||
|
| Glucose | 728.2 | 0.2 to 7.4 | 0.1 | 0.6 | High | 3.59 | 4.22 | - | [ |
| H2O2 | 273.3 | 0.2 to 19.2 | 0.1 | −0.3 | - | - | - | - | ||
|
| Glucose | 33.75 | 6 to 3.369 | 2.6 | 0.6 | High (12 days) | 12.86 | - | Beverage | [ |
| H2O2 | 3.914 | 3 to 2.238 | 1.2 | 0.75 | - | - | - | Contact lens solution | ||
|
| Glucose | 339.35 | 250 to 10 | 16.62 | 0.5 | [ | ||||
| H2O2 | 133.74 | 50 to 10 | 10.93 | −0.40 | ||||||
|
| Glucose | - | 10 to 2.0 | 0.1 | 0.4 | [ | ||||
| H2O2 | - | 10 to 1.7 | 0.1 | 0.7 | ||||||
|
| Glucose | - | - | 1.23 | - | High | - | Good | - | [ |
| H2O2 | - | - | 16.89 | - | - | - | Good | - | ||
|
| Glucose | 4333.7 | 0.1 to 1 | 0.077 | 0.55 | 88.7 | - | 4.8 | Human serum | [ |
| H2O2 | 2273.8 | 0.15 to 8 | 0.059 | −0.20 | 90.2 | - | 3.9 | - | ||
|
| Glucose | 1803 | 2.008 to 7.15 | 0.05 | 0.45 | 92.31 (45 days) | - | 2.6 | Human serum | [ |
| H2O2 | 2848.73 | 0.2 to 3.4985 | 0.2 | 0.0 | 91.05 (45 days) | 3.1 | Human serum |
Sensing parameters of non-enzymatic glucose and H2O2 electrochemical sensors based on metal/metal oxide nanocomposites.
| Electrode Material | Analyte | Sensitivity | Linear Range | Detection Limit | Working Potential | Stability | Repeatability | Reproducibility | Real-Time Application | Ref |
|---|---|---|---|---|---|---|---|---|---|---|
|
| Glucose | 1291 | 10 to 10 | 0.116 | - | [ | ||||
| H2O2 | 32.09 | Up to 80.7 | 0.9 | - | ||||||
|
| Glucose | 285 | 0 to 0.2 | 7 | 0.50 | - | - | - | - | [ |
| H2O2 | 580 | 0 to 3 | 5 | 0.30 | - | - | - | - | ||
|
| Glucose | 643 | 0.05 to 0.2 | 0.008 | 0.55 | 96.2 (20 days) | - | 3.01 | Human serum | [ |
| H2O2 | 1813 | 0.01 to 0.1 | 0.001 | +0.55 | 96.7 (20 days) | - | 2.6 | Toothpaste | ||
|
| Glucose | 1013.8 | 5 to 0.5 | 0.01 | 0.55 | 92.6 (21 days) | - | 2.7 | - | [ |
| H2O2 | 2376.7 | 0.01 to 0.8 | 0.002 | +0.55 | 95.1 (21 days) | - | 3.16 | - | ||
|
| Glucose | 330 | 2 to 3.35 | 0.063 | 0.60 | - | - | - | - | [ |
| H2O2 | 500 | 0.2 to 3.35 | 0.05 | +0.30 | - | - | - | - | ||
|
| Glucose | 42.321 | 1 to 1 | 0.32 | 0.60 | 92.9 (28 days) | - | 5.23 | - | [ |
| H2O2 | 1135.88 | 0.05 to 1 | 0.033 | +0.60 | 94.6 (28 days) | - | 3.18 | - | ||
|
| Glucose | 1239 | 20 to 5.5 | 0.22 | 0.55 | 102.5 (15 days) | 7.4 | 11 | - | [ |
| H2O2 | 219.4 | 500 to 25 | 0.22 | +0.55 | 115.2 | 7.4 | 11 | - | ||
|
| Glucose | - | 1.43 to 3.202 | 0.33 | 0.60 | - | - | <5.0 | Blood plasma | [ |
| H2O2 | 31.9 | 1.0 to 1.618 | 0.094 | −0.35 | - | - | - | Milk | ||
|
| Glucose | 3401.1 | 0.5 to 8.266 | 0.1 | 0.65 | - | - | - | human serum | [ |
| H2O2 | 366.22 | 0.5 to 9.7 | 0.05 | −0.30 | - | - | - | - | ||
|
| Glucose | 4470.4 | 2 to 2.11 | 0.085 | 0.50 | 87.4 (21 days) | 3.9 | 5.02 | human serum | [ |
| H2O2 | 230 | 10 to 1.05 | 1.4 | −0.30 | - | 4.4 | - | - | ||
|
| Glucose | 5350 | 0.5 to 7.67 | 0.35 μM | 0.65 | 93.8 (14 days) | 5.66 | - | human serum | [ |
| H2O2 | 1706.3 | 0.5 to 7.5 | 0.2 μM | 0.60 | 94.5 (14 days) | 4.35 | - | - | ||
|
| Glucose | 2043 | 0.20 to 2.5 | 0.08 | 0.60 | 93.6 (14 days) | 2.4 | 3.1 | human serum | [ |
| H2O2 | 271.1 | 0.30 to 9.0 | 0.09 | −0.35 | - | 3.8 | 5.5 | - | ||
|
| Glucose | 168.7 | 10 to 11.205 | 1.3 | 0.45 | 94.4 (14 days) | - | 4.13 | - | [ |
| H2O2 | 183.3 | 25 to 11.1 | 0.44 | −0.20 | 91.3 (14 days) | - | 2.91 | - | ||
|
| Glucose | 2072 | 5 to 10.95 | 0.39 | 0.50 | 92.5 (28 days) | 5.27 | 8.35 | human serum | [ |
| H2O2 | - | 1 to 0.51 | 0.136 | +0.50 | - | - | - | - |